Purine and pyrimidine (P2) receptors as drug targets.
Jacobson
Kenneth A
KA
Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes, Digestive and Kidney Diseases/NIH, Bethesda, MD 20892, USA.
Jarvis
Michael F
MF
Williams
Michael
M
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D015195:Drug Design; D006801:Humans; D008024:Ligands; D058910:Purinergic P2 Receptor Agonists; D058919:Purinergic P2 Receptor Antagonists; D011743:Pyrimidines / Q000378:metabolism*; D018048:Receptors, Purinergic P2 / Q000737:chemistry / Q000502:physiology; D014544:Uridine Triphosphate / Q000378:metabolism
D008024:Ligands; D058910:Purinergic P2 Receptor Agonists; D058919:Purinergic P2 Receptor Antagonists; D011743:Pyrimidines; D018048:Receptors, Purinergic P2; D000255:Adenosine Triphosphate; D014544:Uridine Triphosphate